{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:22:16Z","timestamp":1789784536156,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bbr.2005.04.011","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T15:46:32Z","timestamp":1118418392000},"page":"159-167","source":"Crossref","is-referenced-by-count":99,"title":["Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: A comparative study in two mouse strains"],"prefix":"10.1016","volume":"163","author":[{"given":"Reena","family":"Haobam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kizhakke M.","family":"Sindhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kochupurackal P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2005.04.011_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(90)90576-W","article-title":"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism","volume":"515","author":"Arai","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib2","first-page":"47","article-title":"Neuropharmacological manipulations with MPTP","volume":"20","author":"Barnes","year":"1986","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.bbr.2005.04.011_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","article-title":"Experimental models of Parkinson's disease","volume":"2","author":"Beal","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bbr.2005.04.011_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0028-3908(86)90016-X","article-title":"The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurones in white and black mice. Antagonism by monoamine oxidase inhibitors","volume":"25","author":"Bradbury","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.04.011_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0361-9230(93)90215-W","article-title":"Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB\/c mice","volume":"31","author":"Chang","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2005.04.011_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2005.04.011_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0969-9961(02)00020-7","article-title":"Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice","volume":"12","author":"Crocker","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.bbr.2005.04.011_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogues","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00702-004-0206-z","article-title":"Effects of riluzole on combined MPTP+3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice","volume":"112","author":"Diguet","year":"2005","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2005.04.011_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(87)90121-3","article-title":"Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treated mouse","volume":"77","author":"Donnan","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.bbr.2005.04.011_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/exnr.2000.7470","article-title":"Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys","volume":"165","author":"Eberling","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2005.04.011_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0028-3908(90)90146-I","article-title":"Behavioural effects of serotonin agonists and antagonists in the rat and marmoset","volume":"29","author":"Elliott","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.04.011_bib13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/BF01923334","article-title":"Genetic factors in neurotoxicology and neuropharmacology: a critical evaluation of the use of genetics as a research tool","volume":"47","author":"Festing","year":"1991","journal-title":"Experientia"},{"key":"10.1016\/j.bbr.2005.04.011_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0306-4522(02)00401-3","article-title":"A \u2018single toxin-double lesion\u2019 rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis","volume":"115","author":"Ghorayeb","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2005.04.011_bib15","first-page":"691","article-title":"Correlation between the neostriatal content of the 1-methyl-4-phenylpyridine species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice","volume":"257","author":"Giovanni","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2005.04.011_bib16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/brain\/119.5.1717","article-title":"Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis","volume":"119","author":"Guridi","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2005.04.011_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/exnr.2000.7588","article-title":"Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility","volume":"168","author":"Hofele","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2005.04.011_bib18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0028-3908(89)90015-4","article-title":"The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice","volume":"28","author":"Hoskins","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2005.04.011_bib19","first-page":"1379","article-title":"Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB\/c mice","volume":"259","author":"Hu","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2005.04.011_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0024-3205(76)90303-9","article-title":"An animal behavior model for studying central serotonergic synapses","volume":"15","author":"Jacobs","year":"1976","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2005.04.011_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02960908","article-title":"Relative resistance of rabbits to MPTP neurotoxicity","volume":"25","author":"Lermontova","year":"1995","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.bbr.2005.04.011_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainres.2003.09.066","article-title":"Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP","volume":"994","author":"Liu","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4274(90)90059-U","article-title":"No apparent difference in the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the sympathetic system in NMRI and C57BL\/6 mice","volume":"54","author":"Luthman","year":"1990","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.bbr.2005.04.011_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1006\/exnr.1996.0167","article-title":"Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys","volume":"141","author":"Melega","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2005.04.011_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0892-0362(98)00037-3","article-title":"MPTP-induced parkinsonism in mini-pigs: a behavioral, biochemical, and histological study","volume":"21","author":"Mikkelsen","year":"1999","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.bbr.2005.04.011_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1471-4159.1991.tb03784.x","article-title":"Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium","volume":"57","author":"Miller","year":"1991","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2005.04.011_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","article-title":"Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrehydropyridine in mice","volume":"28","author":"Mitra","year":"1992","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.bbr.2005.04.011_bib28","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1471-4159.1994.62051906.x","article-title":"Resistance of golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrehydropyridine: relationship with low levels of regional monoamine oxidase-B","volume":"62","author":"Mitra","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2005.04.011_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(90)90175-9","article-title":"Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement","volume":"120","author":"Mohanakumar","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2005.04.011_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","article-title":"Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity","volume":"864","author":"Mohanakumar","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","article-title":"Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice","volume":"12","author":"Muralikrishnan","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.bbr.2005.04.011_bib32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1994.1058","article-title":"Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57\/bl and CD-1 mice","volume":"126","author":"Muthane","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2005.04.011_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.10238","article-title":"The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets","volume":"17","author":"Pearce","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2005.04.011_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0166-4328(99)00171-0","article-title":"Effects of serotoninergic drugs on tremor induced by physostigmine in rats","volume":"109","author":"Sarkar","year":"2000","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jnr.490310116","article-title":"MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment","volume":"31","author":"Schneider","year":"1992","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03033338","article-title":"Strain-dependent recovery of open-field behavior and striatal dopamine deficiency in the mouse MPTP model of Parkinson's disease","volume":"1","author":"Schwarting","year":"1999","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1001958023096","article-title":"MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences","volume":"30","author":"Sedelis","year":"2000","journal-title":"Behav Genet"},{"key":"10.1016\/j.bbr.2005.04.011_bib38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00001756-200004070-00037","article-title":"Evidence for resistance to MPTP in C57BL\/6\u00d7BALB\/c F1 hybrids as compared with their progenitor strains","volume":"11","author":"Sedelis","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2005.04.011_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson's disease","volume":"125","author":"Sedelis","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0197-0186(93)90013-U","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), and gamma-vinyl-gamma-aminobutyric acid (gamma-vinyl GABA) alter neurotransmitter concentrations in the nervous tissue of the goldfish (Carassius auratus) but not the cockroach (Periplaneta americana)","volume":"22","author":"Sloley","year":"1993","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2005.04.011_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/glia.1042","article-title":"Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia","volume":"34","author":"Smeyne","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2005.04.011_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0306-4522(88)90223-0","article-title":"Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway. I. Behavioural, neurochemical and histological characterization of the lesion","volume":"27","author":"Sirinathsinghji","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2005.04.011_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0006-8993(90)91656-2","article-title":"Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL\/6 mice: a model for Parkinson's disease","volume":"528","author":"Sundstrom","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2005.04.011_bib44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0773.1998.tb01428.x","article-title":"Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice","volume":"82","author":"Tariq","year":"1998","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2005.04.011_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2005.04.011_bib46","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF00176480","article-title":"Increased sensitivity of mice to tremorogenic agents following MPP+","volume":"92","author":"Wagner","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2005.04.011_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(88)90443-0","article-title":"Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice","volume":"85","author":"Weihmuller","year":"1988","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2005.04.011_bib48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0091-3057(89)90362-6","article-title":"Dissociation between biochemical and behavioral recovery in MPTP-treated mice","volume":"34","author":"Weihmuller","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2005.04.011_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1531-8257(199907)14:4<557::AID-MDS1004>3.0.CO;2-G","article-title":"Animal models of tremor","volume":"14","author":"Wilms","year":"1999","journal-title":"Mov Disord"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643280500166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643280500166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T18:47:05Z","timestamp":1550947625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643280500166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S016643280500166X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2005.04.011","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}